BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10653885)

  • 21. Radiation recall myelitis following capecitabine: First case report.
    Guerreiro C; Albuquerque L; Reimão S
    Clin Neurol Neurosurg; 2020 Sep; 196():105978. PubMed ID: 32540712
    [No Abstract]   [Full Text] [Related]  

  • 22. Pemetrexed-induced radiation recall dermatitis of the breast.
    Boesmans S; Decoster L; Schallier D
    Anticancer Res; 2014 Mar; 34(3):1179-82. PubMed ID: 24596357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine-Induced Retinopathy.
    Jhaj G; Jhaj R; Shrier EM
    Retina; 2017 Nov; 37(11):e130-e131. PubMed ID: 28961673
    [No Abstract]   [Full Text] [Related]  

  • 24. Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma.
    Patel SC; Paulino AC; Johnston D; Wiederhold L; Castillo R; Venkatramani R
    Pract Radiat Oncol; 2017; 7(1):e19-e22. PubMed ID: 27637134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
    Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
    J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gemcitabine: a new chemotherapy agent for solid cancers].
    Klastersky J; Awada A
    Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
    Retrosi C; Vezzoni R; Conforti C; Corneli P; Magaton-Rizzi G; Zalaudek I; Di Meo N
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Dec; 28(4):185-186. PubMed ID: 31855275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.
    Locker GJ; Wenzel C; Schmidinger M; Gnant MF; Marosi C; Jakesz R; Zielinski CC; Steger GG
    Anticancer Drugs; 2001 Mar; 12(3):209-12. PubMed ID: 11290868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.
    Seidman A
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):9-14. PubMed ID: 14768399
    [No Abstract]   [Full Text] [Related]  

  • 30. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
    Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
    J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
    Saif MW; Black G; Johnson M; Russo S; Diasio R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine-induced radiation recall phenomenon in a post-operative and post-radiotherapy case of peri-ampullary carcinoma during adjuvant chemotherapy.
    Biswas J; Dutta S; Sharma S; Choudhury KB
    J Cancer Res Ther; 2012; 8(3):439-41. PubMed ID: 23174731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine-induced supraventricular tachycardia.
    Tayer-Shifman OE; Rottenberg Y; Shuvy M
    Tumori; 2009; 95(4):547-9. PubMed ID: 19856675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine for palliative treatment in metastatic breast cancer.
    Lüftner D; Flath B; Akrivakis C; Grunewald R; Mergenthaler HG; Possinger K
    J Cancer Res Clin Oncol; 1998; 124(10):527-31. PubMed ID: 9829855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis].
    Kawaguchi Ushio A; Hattori M; Kohno N; Kaise H; Iwata H
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1529-32. PubMed ID: 24231708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary spasm induced by capecitabine.
    Schnetzler B; Popova N; Collao Lamb C; Sappino AP
    Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636
    [No Abstract]   [Full Text] [Related]  

  • 37. Gemcitabine-related radiation recall in a patient with pancreatic cancer.
    Saif MW; Sellers S; Russo S
    Anticancer Drugs; 2006 Jan; 17(1):107-11. PubMed ID: 16317298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
    Bami H; Goodman C; Boldt G; Vincent M
    Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anal pruritus after cancer chemotherapy with gemcitabine.
    Hejna M; Valencak J; Raderer M
    N Engl J Med; 1999 Feb; 340(8):655-6. PubMed ID: 10049089
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent lower extremity pseudocellulitis.
    Korniyenko A; Lozada J; Ranade A; Sandhu G
    Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.